Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Mucous Membrane Pemphigoid and Covid-19 Treated With High-Dose Intravenous Immunoglobulins: A Case Report Publisher Pubmed



Daneshpazhooh M1 ; Soori T2 ; Isazade A1 ; Noormohammadpour P1
Authors

Source: Journal of Dermatological Treatment Published:2020


Abstract

This is a report of a case with mucous membrane pemphigoid (MMP) with severe eye involvement and concurrent COVID-19 treated successfully using simultaneous high dose intravenous immunoglobulin (IVIg) and anti-viral treatment as hydroxychloroquine, lopinavir/ritonavir, and ribavirin. He had finished a 2-g cycle of rituximab (RTX) in late January. He was receiving mycophenolate mofetil (MMF) for one month and 30 mg prednisolone for three months until his hospitalization. Prednisolone was tapered to 15 mg when current COVID-19 was suspected, considering his recent cough, dyspnea, and fever. © 2020, © 2020 Taylor & Francis Group, LLC.
Related Docs
View other Related Docs
1. Covid-19 Pandemic and Biological Therapy in Rheumatologic Disorders: How to Deal With?, Reumatismo (2020)
2. Covid-19, an Early Investigation From Exposure to Treatment Outcomes in Tehran, Iran, Journal of Research in Medical Sciences (2021)
3. Acute Generalized Exanthematous Pustulosis Following Sars-Cov-2 Virus: Remdesivir As a Suspected Culprit, Case Reports in Medicine (2022)
Experts (# of related papers)
View all Related Experts
Zeinab Aryanian (4)
Kamran Balighi (4)
Other Related Docs
4. A Case of Multiple Sclerosis With Protracted Course of Covid-19, Infectious Disorders - Drug Targets (2022)
5. Sars-Cov-2: From the Pathogenesis to Potential Anti-Viral Treatments, Biomedicine and Pharmacotherapy (2021)
6. Covid Outcome in Pemphigus: Does Rituximab Make Pemphigus Patients Susceptible to More Severe Covid-19?, Journal of Cosmetic Dermatology (2023)
7. A Case of Autosomal Recessive Interferon Alpha/Beta Receptor Alpha Chain (Ifnar1) Deficiency With Severe Covid-19, Journal of Clinical Immunology (2022)
8. Renal Involvement in a Child With Covid-19 Infection and Its Management With Crrt, International Journal of Preventive Medicine (2022)
9. Challenges and Advances in Ocular Mucous Membrane Pemphigoid (Ommp); From Pathogenesis to Treatment Strategies, Graefe's Archive for Clinical and Experimental Ophthalmology (2025)
10. Effect of Hydroxychloroquine on Prevention of Covid-19 Virus Infection Among Healthcare Professionals: A Structured Summary of a Study Protocol for a Randomised Controlled Trial, Trials (2020)
11. Acute and Sub-Acute Ocular Manifestations in Pediatric Patients With Covid-19: A Systematic Review, Medical Hypothesis# Discovery# and Innovation in Ophthalmology (2022)
12. Practice Guideline on Prevention, Diagnosis, and Treatment of Rhino-Orbito-Cerebral Mucormycosis in the Covid-19 Area: A Consensus of Iranian Experts, Archives of Clinical Infectious Diseases (2022)
13. A Randomized Clinical Trial of the Efficacy and Safety of Interferon Β-1A in Treatment of Severe Covid-19, Antimicrobial Agents and Chemotherapy (2020)
14. Prevalence and Management of Chronic Hepatitis B in Pemphigus and Pemphigoid Patients: New Evidence for the Safety of Rituximab, Dermatologic Therapy (2022)
15. Interferon Β-1B in Treatment of Severe Covid-19: A Randomized Clinical Trial, International Immunopharmacology (2020)
16. Current Treatments and Therapeutic Options for Covid-19 Patients: A Systematic Review, Infectious Disorders - Drug Targets (2022)
17. Serious Health Threat of Mucormycosis During the Ongoing Covid-19 Pandemic: What Dermatologists Need to Know in This Regard, International Journal of Dermatology (2022)
18. Cardiovascular Complications of Covid-19: Pharmacotherapy Perspective, Cardiovascular Drugs and Therapy (2021)
19. Corona Virus Disease 2019 (Covid-19) As a System-Level Infectious Disease With Distinct Sex Disparities, Frontiers in Immunology (2021)
20. Iranian Guideline for Rituximab Therapy in Pemphigus Patients, Dermatologic Therapy (2019)